Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Quality of care harmed after hospital acquisitions

Hospital acquisitions may have a negative impact on the quality of patient care, according to new findings published in the New England Journal of Medicine. The study results may help answer the question of how mergers and acquisitions impact patients and quality of care.

Thumbnail

Spending bill guts ACA taxes, medical device tax

President Trump signed the latest $1.4 trillion spending bills into law to fund the government and simultaneously gutted three taxes related to the Affordable Care Act: the health insurance tax, Cadillac tax and medical device tax.

Thumbnail

World’s most expensive drug could be free for some in lottery

Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.

Thumbnail

Humana execs sell $38M in shares

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

Thumbnail

Cigna sells non-health business for $6.3B

Cigna, one of the nation’s largest health insurance providers, has agreed to sell its group disability and life insurance business to New York Life for a purchase price of $6.3 billion.

Thumbnail

ACA's individual mandate struck down in court ruling

The individual mandate of the Affordable Care Act, which requires individuals to have health insurance coverage or face a penalty, has been declared unconstitutional by the Fifth Circuit Court. The ruling is a victory for the Republican-led lawsuit to overturn the ACA. However, it still leaves other elements of the ACA without a decision, including the popular provision of healthcare coverage for those with pre-existing conditions.

Thumbnail

Trump administration issues proposal for drug importation plan

The Trump administration, along with HHS and the FDA, have issued a notice of proposed rulemaking (NRPM) for a drug importation plan to allow certain drugs to be purchased from Canada.

Thumbnail

3 key requirements for AI in healthcare to reach its full potential

AI could change healthcare forever. But for the technology to reach its full potential, researchers must make sure they go about things the right way.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.